socalTECH

APRIL 20, 2017

Thousand Oaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. Financial terms of the acquisition were not announced. The acquisition comes just over 12 years after Xirrus was founded by Dirk Gates in 2005.

Thousand Oaks 127

Thousand Oaks Acquisition Startup Networking 127

socalTECH

OCTOBER 23, 2015

Thousand Oaks-based SunBrite TV , a manufacturer of large screen, HDTV screens specifically designed to be installed outdoors, next to pools, on patios, and elsewhere, has been acquired by SnapAV , which is owned by private equity investor General Atlantic. Financial terms of the acquisition were not disclosed. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Screening Equity Acquisition 100

socalTECH

AUGUST 13, 2013

Financial terms of the acquisition were not announced. Wilcon said its network now connects Los Angeles, Burbank, Pasadena, Santa Monica, Woodland Hills, Thousand Oaks, Santa Clarita, Long Beach, Irvine, Riverside, Carlsbad and San Diego. READ MORE>>.

Santa Clarita 147

Santa Clarita Woodland Hills Networking Thousand Oaks 147

socalTECH

APRIL 10, 2012

Thousand Oaks-based biotech giant Amgen said this morning that it has agreed to buy KAI Pharmaceuticals , a developer of treatments for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, for $315M in cash. KAI Pharmaceuticals is based in South San Francisco. READ MORE>>.

Thousand Oaks 160

Thousand Oaks Capital Develop Development 160

socalTECH

JULY 16, 2010

Still on tap for an IPO are Pasadena-based Green Dot , Pasadena-based Genmark Diagnostics , Westlake Village-based Inphi , San Diego-based Fallbrook Technologies , Los Angeles-based GameFly , San Diego-based Trius Therapeutics , City of Industry-based NewEgg , and Thousand Oaks-based Nexsan.

Westlake Village 145

Westlake Village Woodland Hills Thousand Oaks ReachLocal 145

socalTECH

JANUARY 24, 2011

Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development. READ MORE>>.

Thousand Oaks 167

Thousand Oaks Sales Invest Capital 167

socalTECH

FEBRUARY 28, 2012

Thousand Oaks-based Ceres , the developer of seed stock for energy crops, said today that it has closed its IPO, selling a total of 5,750,000 shares of its common stock at $13.00 Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. The firm's IPO was underwritten by Goldman Scahs & Co.,

Thousand Oaks 140

Thousand Oaks Southern California Marketing Capital 140